Letter to "May myo-inositol and D-chiro-inositol (40:1) treatment be a good option on normal-weighted polycystic ovary syndrome patients without insulin resistance?"
J Obstet Gynaecol Res
.
2021 Feb;47(2):860.
doi: 10.1111/jog.14590.
Epub 2020 Dec 2.
Authors
Xin Liu
1
,
Shu-Ping Li
2
Affiliations
1
Changzhou Clinical Medicine School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
2
Department of Gynecology, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, China.
PMID:
33269516
DOI:
10.1111/jog.14590
No abstract available
Publication types
Letter
Comment
MeSH terms
Body Weight
Female
Humans
Inositol
Insulin Resistance*
Polycystic Ovary Syndrome* / drug therapy
Substances
Inositol